Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. Share Price
Equities
688076
CNE1000051X5
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56.03 CNY | +2.30% | +1.74% | +24.65% |
Sales 2024 * | 1.47B 203M 16.19B | Sales 2025 * | 2.02B 279M 22.23B | Capitalization | 11.94B 1.65B 132B |
---|---|---|---|---|---|
Net income 2024 * | 232M 32.05M 2.56B | Net income 2025 * | 329M 45.44M 3.62B | EV / Sales 2024 * | 8.13 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 5.92 x |
P/E ratio 2024 * |
51.5
x | P/E ratio 2025 * |
36.1
x | Employees | 1,545 |
Yield 2024 * |
0.54% | Yield 2025 * |
0.85% | Free-Float | 52.6% |
1 day | +2.30% | ||
1 week | +1.74% | ||
1 month | +4.67% | ||
3 months | +34.36% | ||
6 months | +18.71% | ||
Current year | +24.65% |
Managers | Title | Age | Since |
---|---|---|---|
Zi Quan Tong
CEO | Chief Executive Officer | 54 | 31/08/17 |
Wei Ding
DFI | Director of Finance/CFO | 41 | 05/02/23 |
Biao Liu
CHM | Chairman | 43 | 31/12/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qiang Guo Xu
BRD | Director/Board Member | 60 | 19/05/19 |
Feng Qu
BRD | Director/Board Member | 49 | 19/05/19 |
De Yi Zhao
BRD | Director/Board Member | 61 | 02/04/09 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 56.03 | +2.30% | 2,884,849 |
29/04/24 | 54.77 | -0.54% | 2,815,650 |
26/04/24 | 55.07 | +0.68% | 2,476,239 |
25/04/24 | 54.7 | +1.22% | 2,640,518 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.65% | 1.65B | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- 688076 Stock